SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Continental Advisors LLC

Continental Advisors LLC increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 26,200 shares of the exchange traded fund’s stock after buying an additional 500 shares during the quarter. SPDR S&P Biotech ETF comprises about 1.1% of Continental Advisors LLC’s holdings, making the stock its 22nd biggest position. Continental Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,360,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Demars Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $280,309,000. Proficio Capital Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $55,529,000. Mirae Asset Securities USA Inc. raised its holdings in SPDR S&P Biotech ETF by 66.7% during the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after purchasing an additional 600,000 shares in the last quarter. Finally, J.Safra Asset Management Corp lifted its position in SPDR S&P Biotech ETF by 461.6% in the fourth quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after purchasing an additional 240,415 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $75.51 on Tuesday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The business’s fifty day moving average is $83.47 and its 200-day moving average is $90.92. The stock has a market cap of $4.80 billion, a PE ratio of 11.47 and a beta of 1.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.